Pedro Pablo Martínez-Vega

Expression, purification, immunogenicity, and protective efficacy of a recombinant Tc24 antigen as a vaccine against Trypanosoma cruzi infection in mice

Viridiana Martínez-Campos, Pedro Pablo Martínez-Vega, María Jesús Ramírez-Sierra et al. · Vaccine · 2015 · 59 citations

Vaccination, Mucosal Vaccination, Protective Efficacy +11

Production of recombinant TSA-1 and evaluation of its potential for the immuno-therapeutic control of<i>Trypanosoma cruzi</i>infection in mice

Juan Jose de la Cruz, Liliana Villanueva‐Lizama, Victor Manuel Dzul-Huchim et al. · Human Vaccines & Immunotherapeutics · 2018 · 48 citations · Full text

From Genome Screening to Creation of Vaccine Against<i>Trypanosoma cruzi</i>by Use of Immunoinformatics

Christian Teh‐Poot, Evelyn Tzec-Arjona, Pedro Pablo Martínez-Vega et al. · The Journal of Infectious Diseases · 2014 · 26 citations

Vaccine-linked chemotherapy with a low dose of benznidazole plus a bivalent recombinant protein vaccine prevents the development of cardiac fibrosis caused by Trypanosoma cruzi in chronically-infected BALB/c mice

Victor Manuel Dzul-Huchim, María Jesús Ramírez-Sierra, Pedro Pablo Martínez-Vega et al. · PLoS neglected tropical diseases · 2022 · 23 citations · Full text

Temporal variation of Triatoma dimidiata abundance and infection with Trypanosoma cruzi in domestic and sylvatic habitats of rural Yucatan, Mexico

Joel Moo-Millán, Anette Hernández-Andrade, Irving May-Concha et al. · Acta Tropica · 2023 · 23 citations

Rural Yucatan, Trypanosoma Cruzi, Parasitic Disease +5